Skip to main content
SpringerLink
Log in

Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches

  • Experimental Works
  • Published:
Molecular Genetics, Microbiology and Virology Aims and scope Submit manuscript

Abstract

Recombinant bone morphogenetic protein-2 (rhBMP-2) has pronounced osteoinductive properties, as evidenced by the results of experimental and clinical practices. This applies to both the protein produced in eukaryotic cells and the protein synthesized in bacterial cells. In eukaryotic expression systems, production of the protein is extremely low and, consequently, the cost of materials on its basis is very high. Therefore, optimization of heterologous expression systems for rhBMP-2 production represents an important task. In the present work, optimization of codon composition of the rhBMP-2 gene nucleotide sequence and secondary structure of the transcript, as well as strain selection for efficient gene expression, were carried out. The producing strain based on Escherichia coli BL-21(DE3) provides a high level of rhBMP-2 synthesis (about 57% of total cell proteins). Biological activity of rhBMP-2 dimeric forms purified from the obtained producing strain was measured by induction of alkaline phosphatase activity in C2C12 cells. It is comparable with that of commercial rhBMP-2 expressed in E. coli (R&D Systems, United States). Purified rhBMP-2 does not contain impurities of E. coli endotoxin and can be used in experimental studies of osteoinduction in laboratory animals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zaitsev, V.V., Karyagina, A.S., and Lunin, V.G., Bone morphogenetic proteins (BMPs): General characteristics, prospects of clinical usage in traumatology and orthopedy, Vestn. Travmatol. Ortop. im. N.N. Priorova, 2009, vol. 4, pp. 79–84.

    Google Scholar 

  2. Scheuxer, C., Sebald, W., and Hulsmeyer, M., Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution, J. Mol. Biol., 1999, vol. 287, pp. 103–115. doi 10.1006/jmbi.1999.2590

    Article  Google Scholar 

  3. Sharapova, N.E., Kotnova, A.P., Galushkina, Z.M., Lavrova, N.V., Poletaeva, N.N., Tukhvatulin, A.E., et al., Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo, Mol. Biol. (Moscow), 2010, vol. 44, no. 6, pp. 923–931.

    Article  CAS  Google Scholar 

  4. Yano, K., Hoshino, M., Ohta, Y., Manaka, T., Naka, Y., Imai, Y., et al., Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein- 2 produced by Escherichia coli and dimerized by biochemical processing, J. Bone Miner. Metab., 2009, vol. 27, pp. 355–363. doi 10.1007/s00774-009-0040-3

    Article  CAS  PubMed  Google Scholar 

  5. Bessho, K., Konishi, Y., Kaihara, S., Fujimura, K., Okubo, Y., and Iizuka, T., Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cellderived recombinant human bone morphogenetic protein-2, Br. J. Oral. Maxillofac. Surg., 2000, vol. 38, pp. 645–649. http://dx.doi.org/. doi 10.1054/bjom.2000.0533.

    Article  CAS  PubMed  Google Scholar 

  6. Kim, I.S., Lee, E.N., Cho, T.H., Song, Y.M., Hwang, S.J., Oh, J.H., et al., Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morphogenetic protein-2, Tissue Eng., Part A, 2011, vol. 17, nos. 3–4, pp. 337–348.

    Article  Google Scholar 

  7. Gintsburg, A.L., Karyagina, A.S., Lunin, V.G., and Semikhin, A.S., Development of new generation medicinal products for efficient bone regeneration, Lech. Profil., 2011, vol. 1, pp. 78–81.

    Google Scholar 

  8. Gintsburg, A.L., Sharapova, N.E., Nadezhdin, S.V., Fedorova, M.Z., Karyagina, A.S., and Lunin, V.G., New medicinal products for stimulating bone tissue regeneration, Sovrem. Med. Tekhnol., 2011, vol. 7, pp. 60–62.

    Google Scholar 

  9. Donchenko, S.V., Karyagina, A.S., Alekseev, D.V., and Lunin, V.G., The first experience for applying new generation osteoplastic materials, containing recombinant human bone morphogenetic proteins (rhBMPs) for treating defects and post-traumatic pathology of bone tissue, Mosk. Med. Zh., 2012, vol. 4, pp. 16–21.

    Google Scholar 

  10. Bartov, M.S., Karyagina, A.S., Gromov, A.V., Mishina, D.M., Trunova, G.V., Sidorova, E.I., et al., New generation osteoplastic medicinal products “Gamalant” containing factors of bone tissue growth and regeneration, Kafedra Travmatol. Ortop., 2012, vol. 2, pp. 21–25.

    Google Scholar 

  11. Magamedkhanov, Yu.M., Buravtsova, E.A., Grishkova, N.O., Romashko, N.A., Zakharov, P.A., Kashchenko, P.V., et al., The way for optimizing preimplantation preparation of extracted tooth alveolar socket with the help of Russian material “GamalantTMpaste-FORTE Plus,” Ross. Stomatol. Zh., 2012, vol. 6, pp. 14–15.

    Google Scholar 

  12. Olesova, V.N., Kononenko, V.I., Bersanov, R.U., Kashchenko, P.V., Nikonchuk, E.E., and Chuyanova, E.Yu., Pre-implantation preparation of extracted tooth alveolar socket with the help of Russian material “GamalantTM-paste-FORTE Plus”, Farmateka, 2013, vol. 2, no. 13, pp. 28–30.

    Google Scholar 

  13. Sambrook, J., Fritch, E.F., and Maniatis, T., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press,1989.

    Google Scholar 

  14. Vallejo, L.F., Brokelmann, M., Marten, S., Trappe, S., Cabrera-Crespo, J., Hoffmann, A., et al., Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli, J. Biotechnol., 2002, vol. 94, pp. 185–194. doi 10.1016/s0168-1656(01)00425-4

    Article  CAS  PubMed  Google Scholar 

  15. Ihm, H.J., Yang, S.J., Huh, J.W., Choi, S.Y., and Cho, S.W., Soluble expression and purification of synthetic human bone morphogenetic protein-2 in Escherichia coli, BMB Rep., 2008, vol. 41, no. 5, pp. 404–407. PMID: 18510873

    Article  CAS  PubMed  Google Scholar 

  16. Shineberg, B. and Zipser, D., The Ion gene and degradation of beta-galactosidase nonsense fragments, J. Bacteriol., 1973, vol. 116, no. 3, pp. 1469–1471. PMCID: PMC246507

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Fredriksson, A., Ballesteros, M., Dukan, S., and Nyström, T., Defense against protein carbonylation by DnaK/DnaJ and proteases of the heat shock regulon, J. Bacteriol., 2005, vol. 187, no. 12, pp. 4207–4213. doi 10.1128/JB.187.12.4207-4213.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ruppert, R., Hoffmann, E., and Sebald, W., Human bone morphogenetic protein 2 contains a heparinbinding site which modifies its biological activity, Eur. J. Biochem., 1996, vol. 237, pp. 295–302. doi 10.1111/j.1432-1033.1996.0295n.x

    Article  CAS  PubMed  Google Scholar 

  19. Long, S., Truong, L., Bennett, K., Phillips, A., Wong-Staal, F., and Ma, H., Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli, Protein Expression Purif., 2006, vol. 46, no. 2, pp. 374–378. doi 10.1016/j.pep.2005.09.025

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation, Moscow, 123098, Russia

    A. S. Karyagina, I. S. Boksha, T. M. Grunina, A. V. Demidenko, M. S. Poponova, O. V. Sergienko, A. M. Lyaschuk, Z. M. Galushkina, L. A. Soboleva, E. O. Osidak, A. S. Semikhin, A. V. Gromov & V. G. Lunin

  2. Belozersky Research Institute of Physico-Chemical Biology, Moscow State University, Moscow, 119991, Russia

    A. S. Karyagina

  3. All-Russia Research Institute of Agricultural Biotechnology, Moscow, 127550, Russia

    A. S. Karyagina, O. V. Sergienko & V. G. Lunin

  4. Imtek Ltd., Moscow, 121552, Russia

    E. O. Osidak

Authors
  1. A. S. Karyagina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. S. Boksha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. M. Grunina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. V. Demidenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. S. Poponova
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. V. Sergienko
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. M. Lyaschuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Z. M. Galushkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. A. Soboleva
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. O. Osidak
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. S. Semikhin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. V. Gromov
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. V. G. Lunin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. S. Karyagina.

Additional information

Original Russian Text © A.S. Karyagina, I.S. Boksha, T.M. Grunina, A.V. Demidenko, M.S. Poponova, O.V. Sergienko, A.M. Lyaschuk, Z.M. Galushkina, L.A. Soboleva, E.O. Osidak, A.S. Semikhin, A.V. Gromov, V.G. Lunin, 2016, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2016, No. 4, pp. 132–137.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karyagina, A.S., Boksha, I.S., Grunina, T.M. et al. Optimization of rhBMP-2 active-form production in a heterologous expression system using microbiological and molecular genetic approaches. Mol. Genet. Microbiol. Virol. 31, 208–213 (2016). https://doi.org/10.3103/S0891416816040030

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3103/S0891416816040030

Keywords

Search

Navigation